Integrated Filing — IndAS



General information about company

Scrip Code 540596
NSE Symbol ERIS
MSEI Symbol NOTLISTED
ISIN INE406M01024
Name of company Eris Lifesciences Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 12-11-2025   12:00:00
End date and time of board meeting 12-11-2025   13:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? Yes
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? Yes
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 07-08-2023
Indicate Company website link for updated RPT policy of the Company https://eris.co.in/corporate-governance/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 65,050.00 1,22,914.00
Other income 2,359.00 4,627.00
Total income 67,409.00 1,27,541.00
2 Expenses
(a) Cost of materials consumed 2,029.00 4,441.00
(b) Purchases of stock-in-trade 13,483.00 24,152.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 4,227.00 9,298.00
(d) Employee benefit expense 8,542.00 17,920.00
(e) Finance costs 4,650.00 9,164.00
(f) Depreciation, depletion and amortisation expense 3,930.00 7,690.00
(f) Other Expenses
1 Other Expenses 7,081.00 15,783.00
Total other expenses 7,081.00 15,783.00
Total expenses 43,942.00 88,448.00
3 Total profit before exceptional items and tax 23,467.00 39,093.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 23,467.00 39,093.00
6 Tax expense
7 Current tax 4,091.00 6,808.00
8 Deferred tax 4,419.00 7,329.00
9 Total tax expenses 8,510.00 14,137.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 14,957.00 24,956.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 14,957.00 24,956.00
17 Other comprehensive income net of taxes (50.00) (100.00)
18 Total Comprehensive Income for the period 14,907.00 24,856.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,362.00 1,362.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 10.98 18.32
Diluted earnings (loss) per share from continuing operations 10.96 18.29
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 10.98 18.32
Diluted earnings (loss) per share from continuing and discontinued operations 10.96 18.29
24 Debt equity ratio 0.79 0.79
25 Debt service coverage ratio 2.61 2.38
26 Interest service coverage ratio 6.05 5.27
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 10,638.00
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 4,857.00
Other intangible assets 2,19,739.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 99,076.00
Trade receivables, non-current 0.00
Loans, non-current 30,685.00
Other non-current financial assets 42,955.00
Total non-current financial assets 1,72,716.00
Deferred tax assets (net) 21,061.00
Other non-current assets 4,809.00
Total non-current assets 4,33,820.00
2 Current assets
Inventories 9,840.00
Current financial asset
Current investments 0.00
Trade receivables, current 67,050.00
Cash and cash equivalents 1,042.00
Bank balance other than cash and cash equivalents 285.00
Loans, current 22,709.00
Other current financial assets 4,250.00
Total current financial assets 95,336.00
Current tax assets (net) 0.00
Other current assets 4,696.00
Total current assets 1,09,872.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 5,43,692.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,362.00
Other equity 2,75,695.00
Total equity attributable to owners of parent 2,77,057.00
Non controlling interest
Total equity 2,77,057.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,53,822.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 0.00
Total non-current financial liabilities 1,53,822.00
Provisions, non-current 2,929.00
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 71.00
Total non-current liabilities 1,56,822.00
Current liabilities
Current financial liabilities
Borrowings, current 65,100.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 528.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 24,489.00
Total Trade payable 25,017.00
Other current financial liabilities 7,510.00
Total current financial liabilities 97,627.00
Other current liabilities 1,129.00
Provisions, current 3,683.00
Current tax liabilities (Net) 7,374.00
Deferred government grants, Current 0.00
Total current liabilities 1,09,813.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 2,66,635.00
Total equity and liabilites 5,43,692.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 77.00 154.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (27.00) (54.00)
5 Total Other comprehensive income (50.00) (100.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 39,093.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 9,164.00
Adjustments for decrease (increase) in inventories 9,285.00
Adjustments for decrease (increase) in trade receivables, current (43,431.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 3,952.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 3,409.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 7,690.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (3,266.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 400.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (12,797.00)
Net cash flows from (used in) operations 26,296.00
Dividends received 0.00
Interest paid 0.00
Interest received (3,588.00)
Income taxes paid (refund) 2,525.00
Other inflows (outflows) of cash (544.00)
Net cash flows from (used in) operating activities 19,639.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 20,975.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 9.00
Purchase of property, plant and equipment 2,237.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 119.00
Purchase of other long-term assets (527.00)
Cash advances and loans made to other parties 28,520.00
Cash receipts from repayment of advances and loans made to other parties 1,438.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 68.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (7,621.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 307.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 910.00
Repayments of borrowings 6,125.00
Payments of lease liabilities 382.00
Dividends paid 0.00
Interest paid 14,120.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (19,410.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (7,392.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (7,392.00)
Cash and cash equivalents cash flow statement at beginning of period 8,434.00
Cash and cash equivalents cash flow statement at end of period 1,042.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Walker Chandiok & Co. LLP Yes 31-05-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Interest received 0.00 NA 1.00 0.00 0.00
2 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Royalty Income 0.00 NA 0.00 0.00 0.00
3 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Interest received 0.00 NA 5.00 0.00 0.00
4 APRICA HEALTHCARE LTD ERIS M. J. BIOPHARM PVT LTD Group Company Interest received 28,792.00 Approved on 25-10-2025 54.00 0.00 0.00
5 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Interest received 0.00 NA 7.00 0.00 0.00
6 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Royalty Income 0.00 NA 13.00 0.00 0.00
7 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Royalty Income 0.00 NA 8.00 0.00 0.00
8 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Royalty Income 0.00 NA 3.00 0.00 0.00
9 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Sale of goods or services 28,792.00 Approved on 25-10-2025 4,585.00 0.00 0.00
10 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 28,792.00 Approved on 25-10-2025 1,149.00 0.00 0.00
11 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Cross charge income 0.00 NA 18.00 0.00 0.00
12 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 18.00 0.00 0.00
13 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Sale of goods or services 0.00 NA 121.00 0.00 0.00
14 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Interest received 0.00 NA 1,121.00 0.00 0.00
15 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Cross charge income 0.00 NA 93.00 0.00 0.00
16 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Interest received 0.00 NA 44.00 0.00 0.00
17 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 0.00 0.00 0.00
18 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 83,971.00 0.00 0.00
19 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Cross charge income 28,792.00 Approved on 25-10-2025 18.00 0.00 0.00
20 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Interest received 28,792.00 Approved on 25-10-2025 81.00 0.00 0.00
21 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Sale of goods or services 28,792.00 Approved on 25-10-2025 287.00 0.00 0.00
22 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Cross charge income 0.00 NA 723.00 0.00 0.00
23 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Interest received 0.00 NA 2,274.00 0.00 0.00
24 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Royalty Income 0.00 NA 2,318.00 0.00 0.00
25 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 7.00 0.00 0.00
26 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Cross charge income 28,792.00 Approved on 13-02-2024 77.00 0.00 0.00
27 ERIS THERAPEUTICS LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Sale of goods or services 0.00 NA 224.00 0.00 0.00
28 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Interest received 0.00 NA 189.00 0.00 0.00
29 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Sale of goods or services 0.00 NA 45,969.00 0.00 0.00
30 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Cross charge income 0.00 NA 113.00 0.00 0.00
31 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Interest received 0.00 NA 3.00 0.00 0.00
32 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 0.00 NA 14.00 0.00 0.00
33 ERIS THERAPEUTICS LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Interest received 0.00 NA 2.00 0.00 0.00
34 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Interest received 0.00 NA 140.00 0.00 0.00
35 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Royalty Income 0.00 NA 376.00 0.00 0.00
36 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Sale of goods or services 0.00 NA 141.00 0.00 0.00
37 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Royalty Income 0.00 NA 199.00 0.00 0.00
38 SWISS PARENTERALS LTD APRICA HEALTHCARE LTD Group Company Sale of goods or services 0.00 NA 8.00 0.00 0.00
39 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Interest received 28,792.00 Approved on 13-02-2024 390.00 0.00 0.00
40 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Sale of goods or services 28,792.00 Approved on 13-02-2024 1,891.00 0.00 0.00
41 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 2.00
42 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Collection not due 0.00 NA 0.00 0.00 1.00
43 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 1,805.00
44 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 6.00
45 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Accrued Interest Receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 54.00
46 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 0.00 2,009.00
47 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 7.00
48 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Collection not due 0.00 NA 0.00 0.00 13.00
49 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 275.00
50 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 22.00
51 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 0.00 8.00
52 ERIS HEALTHCARE PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 9.00
53 ERIS HEALTHCARE PVT LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 4.00
54 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 0.00 3.00
55 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 169.00
56 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 233.00
57 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Advance 0.00 NA 0.00 0.00 1.00
58 ERIS M.J. BIOPHARM PVT LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 4,824.00
59 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Advance 28,792.00 Approved on 25-10-2025 0.00 0.00 1.00
60 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 (836.00)
61 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 18.00
62 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 18.00
63 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 41.00
64 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 1,121.00
65 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 30,573.00
66 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 3,595.00
67 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 44.00
68 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 93.00
69 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 0.00
70 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 1,382.00
71 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 48,636.00
72 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Accrued Interest Receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 81.00
73 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Collection not due 28,792.00 Approved on 25-10-2025 0.00 0.00 18.00
74 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 0.00 2,115.00
75 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 344.00
76 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 2,721.00
77 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 723.00
78 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 0.00 2,318.00
79 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 0.00 19,075.00
80 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Other current financial asset 0.00 NA 0.00 0.00 42,244.00
81 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 54.00
82 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Collection not due 28,792.00 Approved on 13-02-2024 0.00 0.00 77.00
83 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 0.00 3.00
84 ERIS THERAPEUTICS LTD APRICA HEALTHCARE LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 11.00
85 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 189.00
86 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 35,474.00
87 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 3.00
88 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 0.00 113.00
89 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 4,845.00
90 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 231.00
91 ERIS THERAPEUTICS LTD ERIS OAKNET HELATHCARE PVT LTD Wholly Owned Subsidiary Any other transaction Accrued Interest Receivable 0.00 NA 0.00 0.00 2.00
92 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Collection not due 0.00 NA 0.00 0.00 376.00
93 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 0.00 4,227.00
94 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 0.00 50.00
95 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 0.00 199.00
96 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 28,792.00 Approved on 13-02-2024 0.00 0.00 10,096.00
97 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 0.00 225.00
98 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 56.00 0.00
99 APRICA HEALTHCARE LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 2,170.00 0.00
100 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Loan closing balance 28,792.00 Approved on 25-10-2025 0.00 759.00 0.00
101 APRICA HEALTHCARE LTD ERIS M.J. BIOPHARM PVT LTD Group Company Any other transaction Other current financial asset 28,792.00 Approved on 25-10-2025 0.00 91.00 0.00
102 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 800.00 0.00
103 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 17.00 0.00
104 APRICA HEALTHCARE LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 4.00 0.00
105 ERIS BIONXT PRIVATE LIMITED ERIS LIFESCIENCES LTD Holding Company Advance 0.00 NA 0.00 5.00 0.00
106 ERIS HEALTHCARE PVT LTD APRICA HEALTHCARE LTD Group Company Advance 0.00 NA 0.00 0.00 0.00
107 ERIS HEALTHCARE PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 9.00 0.00
108 ERIS HEALTHCARE PVT LTD Eris Pharmaceuticals Limited Group Company Any other transaction Loan closing balance 0.00 NA 0.00 2.00 0.00
109 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Advance 0.00 NA 0.00 14.00 0.00
110 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Advance 28,792.00 Approved on 25-10-2025 0.00 49.00 0.00
111 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 28,792.00 Approved on 25-10-2025 0.00 0.00 0.00
112 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 36.00 0.00
113 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 25.00 0.00
114 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 87.00 0.00
115 ERIS LIFESCIENCES LTD ERIS BIONXT PRIVATE LIMITED Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 24,803.00 0.00
116 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Subsidiary Any other transaction Collection not due 0.00 NA 0.00 72.00 0.00
117 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 17.00 0.00
118 ERIS LIFESCIENCES LTD ERIS HEALTHCARE PVT LTD Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 11.00 0.00
119 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Advance 0.00 NA 0.00 886.00 0.00
120 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Advance 0.00 NA 0.00 0.00 0.00
121 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Collection not due 0.00 NA 0.00 36.00 0.00
122 ERIS LIFESCIENCES LTD ERIS M.J. BIOPHARM PVT LTD Subsidiary Any other transaction Loan closing balance 0.00 NA 0.00 1,230.00 0.00
123 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Accrued Interest Receivable 0.00 NA 0.00 447.00 0.00
124 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Collection not due 0.00 NA 0.00 1,241.00 0.00
125 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Other current financial asset 0.00 NA 0.00 63,219.00 0.00
126 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 1,815.00 0.00
127 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Step-down Wholly Owned Subsidiary Advance 0.00 NA 0.00 2.00 0.00
128 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Advance 28,792.00 Approved on 13-02-2024 0.00 84.00 0.00
129 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Collection not due 28,792.00 Approved on 13-02-2024 0.00 149.00 0.00
130 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 21.00 0.00
131 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 3,775.00 0.00
132 ERIS THERAPEUTICS LTD ERIS HEALTHCARE PVT LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 1,580.00 0.00
133 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Collection not due 0.00 NA 0.00 381.00 0.00
134 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 0.00 NA 0.00 157.00 0.00
135 ERIS THERAPEUTICS LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Trade receivable 0.00 NA 0.00 0.00 0.00
136 ERIS OAKNET HELATHCATE PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 21.00 0.00
137 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Advance 0.00 NA 0.00 3.00 0.00
138 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan closing balance 0.00 NA 0.00 3,407.00 0.00
139 ERIS OAKNET HELATHCATE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 316.00 0.00
140 ERIS OAKNET HELATHCATE PVT LTD ERIS THERAPEUTICS LTD Holding Company Any other transaction Trade receivable 0.00 NA 0.00 76.00 0.00
141 SWISS PARENTERALS LTD ERIS BIONXT PRIVATE LIMITED Group Company Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 27.00 0.00
142 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan closing balance 28,792.00 Approved on 13-02-2024 0.00 9,886.00 0.00
143 SWISS PARENTERALS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 139.00 0.00
144 SWISS PARENTERALS LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Trade receivable 0.00 NA 0.00 18.00 0.00
145 SWISS PARENTERALS LTD DEUTSCHE LABS INC Entity of related party Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 95.00 0.00
146 SWISS PARENTERALS LTD HEALTHBEST PVT LTD Entity of related party Any other transaction Trade receivable 28,792.00 Approved on 13-02-2024 0.00 5.00 0.00
147 ERIS LIFESCIENCES LTD Parv Amit Bakshi Relative of related party Remuneration 0.00 Approved on 22-05-2025 0.00 2.00 0.00
148 ERIS LIFESCIENCES LTD Sarthak Negi Relative of related party Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 0.00 0.00 0.00
149 ERIS LIFESCIENCES LTD Amit Bakshi Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 0.00 25.00 0.00
150 ERIS LIFESCIENCES LTD Inderjeet Singh Negi Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 0.00 7.00 0.00
151 ERIS LIFESCIENCES LTD Kaushal Shah Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 0.00 11.00 0.00
152 ERIS LIFESCIENCES LTD Parv Amit Bakshi Relative of related party Remuneration 0.00 Approved on 22-05-2025 0.00 3.00 0.00
153 ERIS LIFESCIENCES LTD Amit Bakshi Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 0.00 3.00 0.00
154 ERIS LIFESCIENCES LTD Kaushal Shah Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 0.00 3.00 0.00
155 ERIS LIFESCIENCES LTD Inderjeet Singh Negi Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 0.00 3.00 0.00
156 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Loan repaid 0.00 NA 650.00 0.00 0.00
157 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Step-down Wholly Owned Subsidiary Any other transaction Loan repaid 0.00 NA 105.00 0.00 0.00
158 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Loan repaid 0.00 NA 157.00 0.00 0.00
159 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Loan repaid 28,792.00 Approved on 13-02-2024 180.00 0.00 0.00
160 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
161 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan repaid 0.00 NA 25.00 0.00 0.00
162 APRICA HEALTHCARE LTD ERIS OAKNET HELATHCATE PVT LTD Group Company Any other transaction Loan repaid 0.00 NA 21.00 0.00 0.00
163 ERIS M.J. BIOPHARM PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
164 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 28,792.00 Approved on 25-10-2025 1,000.00 0.00 0.00
165 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 0.00 NA 225.00 0.00 0.00
166 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
167 ERIS BIONXT PRIVATE LIMITED ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
168 ERIS HEALTHCARE PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
169 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan repaid 0.00 NA 200.00 0.00 0.00
170 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Loan repaid 0.00 NA 0.00 0.00 0.00
171 ERIS LIFESCIENCES LTD APRICA HEALTHCARE LTD Step-down Wholly Owned Subsidiary Any other transaction Loan taken 0.00 NA 125.00 0.00 0.00
172 ERIS LIFESCIENCES LTD ERIS OAKNET HELATHCATE PVT LTD Step-down Wholly Owned Subsidiary Any other transaction Loan taken 0.00 NA 785.00 0.00 0.00
173 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Loan taken 0.00 NA 0.00 0.00 0.00
174 ERIS LIFESCIENCES LTD SWISS PARENTERALS LTD Subsidiary Any other transaction Loan taken 28,792.00 Approved on 13-02-2024 0.00 0.00 0.00
175 ERIS THERAPEUTICS LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan taken 0.00 NA 19,075.00 0.00 0.00
176 APRICA HEALTHCARE LTD ERIS LIFESCIENCES LTD Group Company Any other transaction Loan taken 0.00 NA 0.00 0.00 0.00
177 APRICA HEALTHCARE LTD ERIS OAKNET HELATHCATE PVT LTD Group Company Any other transaction Loan taken 0.00 NA 0.00 0.00 0.00
178 ERIS M.J. BIOPHARM PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan taken 28,792.00 Approved on 25-10-2025 1,250.00 0.00 0.00
179 ERIS M.J. BIOPHARM PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan taken 28,792.00 Approved on 25-10-2025 1,885.00 0.00 0.00
180 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan taken 0.00 NA 300.00 0.00 0.00
181 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Loan taken 0.00 NA 70.00 0.00 0.00
182 ERIS BIONXT PRIVATE LIMITED ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan taken 0.00 NA 5,770.00 0.00 0.00
183 ERIS HEALTHCARE PVT LTD APRICA HEALTHCARE LTD Group Company Any other transaction Loan taken 0.00 NA 1,750.00 0.00 0.00
184 ERIS HEALTHCARE PVT LTD ERIS LIFESCIENCES LTD Holding Company Any other transaction Loan taken 0.00 NA 1,490.00 0.00 0.00
185 ERIS HEALTHCARE PVT LTD ERIS THERAPEUTICS LTD Group Company Any other transaction Loan taken 0.00 NA 1,000.00 0.00 0.00
186 ERIS THERAPEUTICS LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Loan given 0.00 NA 8,000.00 0.00 0.00
187 ERIS THERAPEUTICS LTD ERIS OAKNET HELATHCATE PVT LTD Wholly Owned Subsidiary Any other transaction Loan received back 0.00 NA 8,002.00 0.00 0.00
188 ERIS LIFESCIENCES LTD Amit Bakshi Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 246.00 0.00 25.00
189 ERIS LIFESCIENCES LTD Kaushal Shah Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 86.00 0.00 7.00
190 ERIS LIFESCIENCES LTD Inderjeet Singh Negi Director of Eris Lifesciences Ltd. Remuneration 0.00 Approved on 30-06-2025 64.00 0.00 10.00
191 ERIS LIFESCIENCES LTD Sarthak Negi Relative of related party Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 3.00 0.00 0.00
192 ERIS LIFESCIENCES LTD Parv Bakshi Relative of related party Remuneration 0.00 Approved under omnibus mechanism on 22-05-2025 27.00 0.00 3.00
193 ERIS LIFESCIENCES LTD ERIS THERAPEUTICS LTD Wholly Owned Subsidiary Any other transaction Investment repaid 0.00 NA 20,975.00 0.00 0.00
194 SWISS PARENTERALS LTD Swiss Pharma Private Limited Entity of related party Purchase of goods or services 0.00 NA 22.00 0.00 0.00
195 SWISS PARENTERALS LTD Deutsche Labs Inc. Entity of related party Purchase of goods or services 0.00 NA 179.00 0.00 0.00
196 SWISS PARENTERALS LTD Deutsche Labs Inc. Entity of related party Any other transaction Trade receivable 0.00 NA 0.00 0.00 8.00
197 SWISS PARENTERALS LTD Healthbest Pvt.Ltd. Entity of related party Any other transaction Reimbursement Expenses 0.00 NA 13.00 0.00 0.00
198 SWISS PARENTERALS LTD Healthbest Pvt.Ltd. Entity of related party Any other transaction Trade payable 0.00 NA 0.00 0.00 3.00
199 SWISS PARENTERALS LTD Healthbest Pvt.Ltd. Entity of related party Any other transaction Rent 0.00 NA 9.00 0.00 0.00
200 SWISS PARENTERALS LTD Mr. Naishadh V Shah Entity of related party Remuneration 0.00 NA 101.00 0.00 24.00
Total value of transaction during the reporting period 2,20,445.00